For people struggling with both diabetes and a common type of heart failure, the weight-loss drug Wegovy may do more for their health than help them shed pounds, new research suggests. In the study, published Saturday in the New England Journal of Medicine, researchers reported that the drug helped people with type 2 diabetes who… read on > read on >
People who’ve survived a heart attack and have been given a stent may be better off quitting low-dose aspirin a month after the procedure, a new study finds. The strategy is “beneficial by reducing major and minor bleeding through one year by more than 50 percent,” said study lead author Dr. Gregg Stone, a professor… read on > read on >
Pregnancy transforms women’s bodies in many obvious ways, but new research suggests it may also accelerate aging. Women who had been pregnant appeared to be biologically older than women who had never carried a child, the genetic analysis revealed. Further, more pregnancies meant more aging. “Our findings suggest that pregnancy speeds up biological aging, and… read on > read on >
A custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to shrink liver cancer as when a patient received immunotherapy alone, a new study shows. The vaccine could help liver cancer patients live longer, as fewer than one in 10 survive five years after their diagnosis, the researchers noted. In fact, about 8%… read on > read on >
Spring is in the air, and along with it loads of tree, grass and weed pollen. Sneezing, watery and itchy eyes, runny nose and all the other miseries of seasonal allergies can prevent a person from fully enjoying the season of rebirth. Worse, seasonal allergies also can trigger or worsen asthma, or lead to health… read on > read on >
Today is your last chance until 2044 to see a total eclipse of the sun in the continental United States. But be sure to protect your eyes if you plan to watch the moon block the sun’s rays, briefly plunging Earth into temporary darkness. “The eclipse will last a few minutes,” said Dr. David Hinkle,… read on > read on >
New research questions the effectiveness of the U.S. Food and Drug Administration’s accelerated drug approval program after finding that many cancer drugs remain unproven five years later. The study, published Sunday in the Journal of the American Medical Association and presented simultaneously at the American Association of Cancer Research’s annual meeting in San Diego, found… read on > read on >
A pancreatic cancer vaccine has continued to protect a small group of patients from their cancer coming back, three years after receiving the jab, a new study says. Eight patients have not had their pancreatic cancer recur for three years after their immune systems responded to the vaccine, which is called autogene cevumeran, researchers reported… read on > read on >
Just a little exposure to secondhand smoke may increase your risk for the heart rhythm disorder atrial fibrillation (A-Fib), a new, large study suggests. People who have A-Fib, the world’s most common heart rhythm disorder, are five times more likely to have a stroke than their healthy peers. While passive smoking has been linked to… read on > read on >
A new oral vaccine could prove a potential alternative to antibiotics for people with recurring urinary tract infections, a new study says. More than half of patients with recurring UTIs (54%) wound up infection-free for nine years after receiving the oral spray vaccine, with no notable side effects, researchers report. “Before having the vaccine, all… read on > read on >
